However, recent systematic reviews and meta-analyses in mood disorders and neurodegenerative diseases emphasise both the variability and methodological challenges of using peripheral BDNF and CRP for biomarker-informed stratification. This evidence concerns the gene BDNF and neurodegenerative disease.